DrugPatentWatch Database Preview

Details for Patent: 7,052,679

« Back to Dashboard

Which drugs does patent 7,052,679 protect, and when does it expire?

Patent 7,052,679 protects ADASUVE and is included in one NDA.

This patent has one hundred and ninety-five patent family members in nineteen countries.

Summary for Patent: 7,052,679

Title:	Delivery of antipsychotics through an inhalation route
Abstract:	The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a method aspect of the present invention, an antipsychotic is delivered to a patient through an inhalation route. The method comprises: a) heating a thin layer of an antipsychotic, on a solid support, to form a vapor; and, b) passing air through the heated vapor to produce aerosol particles having less than 5% antipsychotic drug degradation products. In a kit aspect of the present invention, a kit for delivering an antipsychotic through an inhalation route is provided which comprises: a) a thin film of an antipsychotic and b) a device for dispensing said thin film as a condensation aerosol.
Inventor(s):	Rabinowitz; Joshua D. (Mountain View, CA), Zaffaroni; Alejandro C. (Atherton, CA)
Assignee:	Alexza Pharmaceuticals, Inc. (Palo Alto, CA)
Application Number:	10/767,115
Patent Claim Types: see list of patent claims	Delivery; Use;

Drugs Protected by US Patent 7,052,679

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Galen Uk	ADASUVE	loxapine	POWDER;INHALATION	022549-001	Dec 21, 2012		RX	Yes	Yes			Y

Non-Orange Book US Patents Family Members for Patent 7,052,679

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,445,768	Delivery of sedative-hypnotics through an inhalation route
7,063,831	Delivery of erectile dysfunction drugs through an inhalation route
7,987,846	Method and apparatus for vaporizing a compound
7,601,337	Delivery of antipsychotics through an inhalation route

International Patents Family Members for US Patent 7,052,679

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	365548
Austria	401063
Austria	401064
Austria	404173